Contenido multimedia no disponible por derechos de autor o por acceso restringido. Contacte con la institución para más información.
MAP20210020810Leverenz, JustinChina healthcare : a growing force / Justin Leverenz. — Atlanta : Invesco, 2021En: Invesco. - 28 May 2021Sumario: Over the past few years, the Chinese health care system has undergone significant reform. Initiatives to stimulate innovation, especially around drug research and development (R&D), have been the most impactful, in our view. The result is a booming drug R&D ecosystem including quality biotechs and their R&D outsourcing partner companies1. Salud. 2. Biotecnología. 3. Innovación. 4. China. I. Invesco.